-
Following the Ernst & Young report Beyond borders Matters of Evidence 2013 that biotechnology companies worldwide have boosted profits by 37 percent to a record $5.2 billion in 2012, party by tempering growth in R&D spending, Pharma IQ spoke to Ana Nicholls, Healthcare Analyst at The Economist Intelligence Unit, about the key findings of the report and the challenges that...Full Article »
In part two of this interview Dan Sfera from The Clinical Trials Guru, speaks to Andrea Charles from Pharma IQ, about addressing pain points in early phase clinical trials and a dramatic transformation in healthcare delivery. Did you miss part one read here: http://www.pharma-iq.com/clinical/articles/fda-concerned-about-lack-of-pi-oversight-in-early/ Pharma...Full Article »
Events of Interest-
Compound Management & Integrity Online 2011
November 14, 2011
Register Now -
Regenerative Medicine and Barriers to Commercialisation Online Summit 2011
October 25, 2011
Register Now -
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now -
Drive Successful Commercial Product Launches through Effective Key Packaging
February 7, 2013
Register Now
Confirm your Details
|
|
Please confirm the following details to complete
the sign up process. |





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!